$OKYO
OKYO Pharma Limited Ordinary Shares
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$1.41
▼-3.42%-$0.050
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateOKYO Pharma Limited Ordinary Shares
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is OKYO down today? It is at $1.41 (-3.42%), and our scanner flagged it 2 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment OKYO spikes, and full due diligence on OKYO — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $OKYO 2 times in the last 30 days. Create a free account to track $OKYO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on OKYO from our scanner (live price and day move above). Fresh from the SEC: OKYO Pharma Ltd filed a Foreign issuer report (6-K). A material company disclosure like this is often the real catalyst behind a move of this size.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Patil Rajkumar V. Officer | Acquired (grant/award) | +3K | added 20% | 20K | $5K at $1.49 | Jul 27, 26 |
Dempsey Robert John Officer | Acquired (grant/award) | +15K 0.03% of company | n/a | 15K | $23K at $1.54 | Jul 22, 26 |
Mantelli Flavio Officer | Acquired (grant/award) | +20K 0.04% of company | n/a | 20K | $28K at $1.40 | Jul 21, 26 |
Jacob Gary S Officer | Acquired (grant/award) | +4K | added 3.2% | 112K | $5K at $1.40 | Jul 21, 26 |
Cerrone Gabriele M Director | Acquired (grant/award) | +23K 0.04% of company | added 0.2% | 10.87M | $33K at $1.45 | Jul 21, 26 |
Brancaccio John P Director | Acquired (grant/award) | +5K | added 17% | 35K | $7K at $1.48 | Jul 21, 26 |
Cerrone Gabriele M Director | Acquired (grant/award) | +25K 0.05% of company | added 0.2% | 10.85M | $35K at $1.40 | Jul 20, 26 |
Cerrone Gabriele M Director | Acquired (grant/award) | +300K 0.6% of company | added 2.8% | 10.83M | $516K at $1.72 | Jun 8, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on OKYO from our scanner (live price and day move above). Fresh from the SEC: OKYO Pharma Ltd filed a Foreign issuer report (6-K). A material company disclosure like this is often the real catalyst behind a move of this size.
OKYO last traded at $1.41, down 3.42% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The OKYO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged OKYO 2 times in the last 30 days.
OKYO (OKYO Pharma Limited Ordinary Shares) trades on XNAS, with a market cap of about $77M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge OKYO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$OKYO discussion
Sign in to ask a question or join the discussion.